Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 4sanofi-aventis Canada Inc.
02 1Borden Ladner Gervais LLP
03 1Blank
01 32169356
02 32310960
01 6Sevelamer hydrochloride
01 2Capsule
02 4Tablet
01 62014-08-10
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2014-08-10
Date Granted : 2003-05-27
Brand Name : RENAGEL
Patent Number : 2310960
Filing Date : 1994-08-10
Strength per Unit : 400 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-08-10
Date Granted : 2003-05-27
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2014-08-10
Date Granted : 2003-05-27
Brand Name : RENAGEL
Patent Number : 2310960
Filing Date : 1994-08-10
Strength per Unit : 800 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-08-10
Date Granted : 2003-05-27
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2014-08-10
Date Granted : 2000-07-04
Brand Name : RENAGEL
Patent Number : 2169356
Filing Date : 1994-08-10
Strength per Unit : 400 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-08-10
Date Granted : 2000-07-04
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2014-08-10
Date Granted : 2000-07-04
Brand Name : RENAGEL
Patent Number : 2169356
Filing Date : 1994-08-10
Strength per Unit : 800 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-08-10
Date Granted : 2000-07-04
Patent Expiration Date : 2014-08-10
Date Granted : 2003-05-27
Brand Name : RENAGEL
Patent Number : 2310960
Filing Date : 1994-08-10
Strength per Unit : 403 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-08-10
Date Granted : 2003-05-27
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2014-08-10
Date Granted : 2000-07-04
Brand Name : RENAGEL
Patent Number : 2169356
Filing Date : 1994-08-10
Strength per Unit : 403 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-08-10
Date Granted : 2000-07-04
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?
